Evidence map›Paper›PMID 35404045›Full record

ArticleAnalytical chemistry2022

Goslin 2.0 Implements the Recent Lipid Shorthand Nomenclature for MS-Derived Lipid Structures.

Dominik Kopczynski, Nils Hoffmann, Bing Peng, Gerhard Liebisch, Friedrich Spener, Robert Ahrends

Abstract read
In one paragraph

Article in Analytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. New Analytical Technologies to Resolve, Interpret, and Understand Lipid Complexity.Annual review of analytical chemistry (Palo Alto, Calif.) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Challenges and perspectives for naming lipids in the context of lipidomics.Metabolomics : Official journal of the Metabolomic Society · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dominik KopczynskiInstitute of Analytical Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-5885-4568
Nils HoffmannCenter for Biotechnology (CeBiTec), Bielefeld University, 33594 Bielefeld, Germany.ORCID 0000-0002-6540-6875
Bing PengDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, 17176 Stockholm, Sweden.ORCID 0000-0001-5006-7041
Gerhard LiebischInstitute of Clinical Chemistry and Laboratory Medicine, Regensburg University Hospital, 93053 Regensburg, Germany.ORCID 0000-0003-4886-0811
Friedrich SpenerDepartment of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Robert AhrendsInstitute of Analytical Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-0232-3375

Funding

Austrian Science Fund FWF P 33298
6 · The paper itself

Abstract

Goslin is the first grammar-based computational library for the recognition/parsing and normalization of lipid names following the hierarchical lipid shorthand nomenclature. The new version Goslin 2.0 implements the latest nomenclature and adds an additional grammar to recognize systematic IUPAC-IUB fatty acyl names as stored, e.g., in the LIPID MAPS database and is perfectly suited to update lipid names in LIPID MAPS or HMDB databases to the latest nomenclature. Goslin 2.0 is available as a standalone web application with a REST API as well as C++, C#, Java, Python 3, and R libraries. Importantly, it can be easily included in lipidomics tools and scripts providing direct access to translation functions. All implementations are open source.

Indexed as

ShorthandDatabases, FactualLipidomicsLipidsSoftwareLipids

Identifiers

PMID35404045
PMCPMC9047418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.